Skip to main content
. 2021 Aug 10;2021:6546780. doi: 10.1155/2021/6546780

Figure 3.

Figure 3

Recent trends in clinical trials using MSCs. Proportion of country (a), disease conditions (b), autologous or allogeneic (c), and sources of MSCs (d) in recent clinical trials.